NEW YORK, Oct. 3, 2023 /PRNewswire/ — AEYE Health, a leading provider of AI-based diabetic retinopathy (DR) screening solution, today announced that it has significantly reduced the processing time for its best-in-class AEYE-DS diabetic retinopathy screening system to under 5 seconds. This improvement is the result of smarter utilization of computing resources that accelerate the execution of the AI algorithms.

Read more here.

Leave a Reply

Your email address will not be published. Required fields are marked *